Efficacy of Oncolytic Herpes Simplex Virus T-VEC Combined with BET Inhibitors as an Innovative Therapy Approach for NUT Carcinoma. [PDF]
Cancers (Basel), 2022 Ohnesorge PV +11 more
europepmc +1 more source
Enhanced Antitumoral Activity of Encapsulated BET Inhibitors When Combined with PARP Inhibitors for the Treatment of Triple-Negative Breast and Ovarian Cancers. [PDF]
Cancers (Basel), 2022 Juan A +9 more
europepmc +1 more source
Discovery of Highly Potent BET Inhibitors based on a Tractable Tricyclic Scaffold. [PDF]
ACS Med Chem LettZaidi JM +5 more
europepmc +1 more source
BET inhibitors repress expression of interferon-stimulated genes and synergize with HDAC inhibitors in glioblastoma. [PDF]
Neuro Oncol, 2021 Gusyatiner O +7 more
europepmc +1 more source
ARID1A Governs Genomic Stability and Proliferation in SCLC via c-MYC/PARP1 Suppression Driving Vulnerability to BET Inhibitors. [PDF]
Research (Wash D C)Cao G +8 more
europepmc +1 more source
Are BET Inhibitors yet Promising Latency-Reversing Agents for HIV-1 Reactivation in AIDS Therapy? [PDF]
Viruses, 2021 Salahong T, Schwartz C, Sungthong R.
europepmc +1 more source
NLRP3 inflammasome-driven hemophagocytic lymphohistiocytosis occurs independent of IL-1β and IL-18 and is targetable by BET inhibitors. [PDF]
Sci AdvShojaee F +14 more
europepmc +1 more source
BET inhibitors reduce tumor growth in preclinical models of gastrointestinal gene signature-positive castration-resistant prostate cancer. [PDF]
J Clin InvestShukla S +20 more
europepmc +1 more source
Resistance to BET inhibitors in lung adenocarcinoma is mediated by casein kinase phosphorylation of BRD4. [PDF]
Oncogenesis, 2021 Calder J +4 more
europepmc +1 more source